Meningokokken impf

Generic name
Meningokokken impf
Brand name
ATC Code
J07AH
Compare …

Meningokokken impf

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information is present at this moment.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Vaccination regimen meningococci C
  • Intramuscular
    • 2 months up to 18 years

      • NeisVac-C® (polysaccharide conjugate vaccine)

        • Basic immunisation:
          • 2 - <4 months: 2 doses (interval: at least 2 months)
          • ≥ 4 months: 1 dose
        • Booster vaccination:
          • after basic immunisation at the age of <12 months: at least 6 months after last dose, at the age of 12-13 months
          • after basic immunisation at the age of ≥ 12 months: none

        MENJUGATE (conjugate vaccine)

        • Basic immunisation:
          • 2 - <12 months: 2 doses (interval: at least 2 months)
          • ≥ 12 months: 1 dose
        • Booster vaccination:
          • after basic immunisation at the age of <12 months: 1 dose
          • after basic immunisation at the age of ≥ 12 months: none
    • 2 months up to 18 years

      • NeisVac-C® (polysaccharide conjugate vaccine)

        • Basic immunisation:
          • 2 - <4 months: 2 doses (interval: at least 2 months)
          • ≥ 4 months: 1 dose
        • Booster vaccination:
          • after basic immunisation at the age of <12 months: at least 6 months after last dose, at the age of 12-13 months
          • after basic immunisation at the age of ≥ 12 months: none

        MENJUGATE (conjugate vaccine)

        • Basic immunisation:
          • 2 - <12 months: 2 doses (interval: at least 2 months)
          • ≥ 12 months: 1 dose
        • Booster vaccination:
          • after basic immunisation at the age of <12 months: 1 dose
          • after basic immunisation at the age of ≥ 12 months: none
Vaccination regimen meningococci B
  • Intramuscular
    • 2 months up to 18 years

      • Bexsero (component vaccine)

        • 2 months to <6 months:
          • Basic immunisation: 3 doses (at least 1 month apart) OR 2 doses (at least 2 months apart)
          • Booster immunisation: 12-15 months: 1 dose (interval: at least 6 months from the last dose)
        • ≥6 months to <24 months:
          • Basic immunisation: 2 doses (interval: at least 2 months)
          • Booster vaccination:
            • ≥ 6 - <12 months: 1 dose  (in the second year of life; interval: at least 2 months from the last dose)
            • ≥ 12 - <24 months: 1 dose (interval: 12 to 23 months from the last dose)
        • ≥2 years:
          • Basic immunisation: 2 doses (interval: at least 1 month)
          • Booster vaccination: if the risk of invasive meningococcal disease persists

        Trumenba® (recombinant vaccine, adsorbed)

        • ≥ 10 years:
          • Basic immunisation: 2 doses (interval: 6 months) OR 3 doses (interval: at least 1 month between 1st and 2nd dose and at least 4 months between 2nd and 3rd dose)
          • Booster vaccination: After each dosing regimen, a booster dose may be given in persons in whom the risk of invasive meningococcal disease is persistent
        •  
Vaccination regimen meningococci ACWY
  • Intramuscular
    • 6 weeks up to 18 years

      • Nimenrix® (conjugate vaccine)

        • Basic immunisation:
          • 6 weeks - <6 months: 2 doses (interval: 2 months)
          • ≥ 6 months: 1 dose
        • Booster vaccination:
          • for basic immunisation at age <12 months: 1 dose at the age of 12 months (interval: at least 2 months from the last dose)
          • for basic immunisation with conjugate or simple polysaccharide vaccine: from age >12 months: 1 dose

        MenQuadfi® (conjugate vaccine)

        • Basic immunisation:
          • ≥12 months: 1 dose
        • Booster vaccination: MenQuadfi® can be administered as a booster vaccination in 1 dose  to persons who have previously received a basic meningococcal immunisation with a meningococcal vaccine with the same serogroups.

        Menveo (conjugate vaccine)

        • Basic immunisation:
          • ≥2 years: 1 dose
        • Booster vaccination: Menveo can be administered as a booster vaccination to persons who have received a basic immunisation with Menveo, other meningococcal conjugate vaccines or unconjugated meningococcal polysaccharide vaccines. For persons previously vaccinated with Menveo, the necessity and timing of such a booster vaccination must be determined in accordance with national recommendations.

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

VACCINES

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

BACTERIAL VACCINES
J07AN01
J07AE01
J07AJ52
J07AG01
J07AH09
J07AH07
J07AH08
J07AL02
J07AP03
J07AP01
VIRAL VACCINES
J07BP01
J07BN01
J07BX04
J07BC20
J07BC02
J07BC01
J07BM03
J07BM02
J07BB02
J07BB02
J07BA02
J07BD52
J07BF03
J07BG01
J07BH01
J07BA01
J07BK01
J07BL01
BACTERIAL AND VIRAL VACCINES, COMBINED
J07CA09
J07CA06
J07CA02
J07CA01

References

Changes

Therapeutic Drug Monitoring


Overdose